Membranous nephropathy;Glomérulonéphrite extramembraneuse

Revue du Praticien

Volumn 53, Issue 18, 2003, Pages 2033-2038

  Passos, Elsa Martin ^b   Legallicier, Bruno ^b   Godin, Michel ^a  

^a Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT;

CANCER; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; HUMAN; HYPERLIPIDEMIA; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY VEIN THROMBOSIS; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PROGNOSIS; PROTEINURIA; REVIEW; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS INFECTION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BASEMENT MEMBRANE; CHILD; CHILD, PRESCHOOL; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYCLOSPORINS; DRUG THERAPY, COMBINATION; ENGLISH ABSTRACT; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMAN; HYPERLIPIDEMIA; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; INFANT; KIDNEY GLOMERULUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PROGNOSIS; PROTEINURIA; RENAL VEINS; SEX FACTORS; VENOUS THROMBOSIS;

EID: 0346252173     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Cattran DC. Idiopathic membranous glomerulonephritis. Kidney Int 2001; 59: 1983-94.
2. Rosen S, Tornroth T, Bernard DB. Membranous glomerulonephritis. In: Tisher CC, Brenner BM (eds). Renal pathology with clinical and functional correlations, 2nd edition, Philadelphia: JB Lippincott Company, 1994: 258-93.
3. Sarasin FP, Schifferli JA. Prophylactic oral anticoagulation in nephrotic patients with idiopathic membranous nephropathy. Kidney Int 1994; 45: 578-85.
4. Cattran DC. Membranous nephropathy: Quo vadis? Kidney Int 2002; 61: 349-50.
5. Hogan SL, Muller KE, Jennette JC, Falk RJ. A review of therapeutic studies of idiopathic membranous glomerulopathy. Am J Kidney Dis 1995; 25: 862-75.
6. Schieppati A, Mosconi L, Perna A et al. Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 1993; 329: 85-9.
7. Cattran DC, Pei Y, Greenwood CMT, Ponticelli C, Passerini P, Honkanen E. Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications. Kidney Int 1997; 51: 901-7.
8. Cattran DC. Membranous nephropathy. In: Greenberg A (ed). Primer on kidney diseases. New York: Academic Press, 2001: 158-64.
9. Fillastre JP, Godin M. Complications rénales des médicaments. Encycl Med Chir (Paris), Rein-Organes gé nito-urinaires, 18066 Y10, 5-1989, 22p.
10. Etienne I, Moulin B, Godin M et al. Faut-il traiter les syndromes néphrotiques de l'adulte secondaires à une glomé rulonéphrite extramembraneuse idiopathique? Une approche par analyse de décision. Nephrologie 1992; 13: 215-20.
11. Couchoud C, Laville M, Boissel JP. Treatment of membranous nephropathy: a meta-analysis. Nephrol Dial Transplant 1994; 9: 469-70.
12. Imperiale TF, Goldfarb S, Berns JS. Are cytotoxic agents beneficial in idiopathic membranous nephropathy? A meta-analysis of the controlled trials. J Am Soc Nephrol 1995; 5: 1553-8.
13. Juillard L, Fouque D. Traitement des glomérulonéphrites extramembraneuses idiopathiques. Presse Med 2000; 29: 923-9.
14. Ponticelli C, Zucchelli P, Passerini P, Cagnoli L et al. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 1989; 320: 8-13.
15. Ponticelli C, Zucchelli P, Passerini P, Cesana B. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephopathy Treatment Study Group. N Engl J Med 1992; 27: 599-603.
16. Ponticelli C, Zucchelli P, Passerini P et al. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 1995; 48: 1600-4.
17. Ponticelli C, Altieri P, Scolari F et al. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol 1998; 9: 444-50.
18. Cattran DC, Appel GB, Hebert LA et al. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int 2001; 59: 1484-90.
19. Badid C, Babici D, Laville M. Place du mycophénolate mofétil dans les glomérulopathies. Presse Med 2003; 32: 1277-82.
20. Torres A, Dominguez-Gil B, Carreno A et al. Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy. Kidney Int 2002; 61: 219-27.